A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha 1-oleate

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10432520" target="_blank" >RIV/00064203:_____/21:10432520 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/21:10432520

Result on the web

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=WSXW.ihzCe" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=WSXW.ihzCe</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/23723556.2021.1974278" target="_blank" >10.1080/23723556.2021.1974278</a>

Result language

angličtina

Original language name

A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha 1-oleate

Original language description

The protein-lipid complex alphal-oleate, derived from HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells), is identified as a molecular entity with significant therapeutic potential. Structural characterization of the complex and results of a successful placebo-controlled clinical trial are presented.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30217 - Urology and nephrology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Molecular and Cellular Oncology [online]

ISSN

2372-3556

e-ISSN

—

Volume of the periodical

8

Issue of the periodical within the volume

5

Country of publishing house

US - UNITED STATES

Number of pages

3

Pages from-to

—

UT code for WoS article

000702674000001

EID of the result in the Scopus database

2-s2.0-85116386998